Drug Approval | December 20, 2025
GSK’s Exdensur gains FDA nod for severe asthma with just two doses a year
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
The company has improved access to quality healthcare for seniors across both urban and rural areas
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Aims to build the largest connected healthcare ecosystem in India
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Women of all ages will get round-the-clock access to comprehensive treatment
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Subscribe To Our Newsletter & Stay Updated
